ABOUT US
SOLTI (https://www.gruposolti.org/) is a leading cooperative group in the field of clinical cancer research. With a consolidated track record of more than 30 years, its main activity focuses on the design and execution of translational clinical studies within the academic field. The main focus is on breast cancer, but its scope covered includes other tumors. With the accumulated experience of 115 clinical trials and more than 40 in progress, SOLTI gathers the work of 500 researchers from a network comprising more than 100 hospitals in Spain, Portugal and Ireland all coordinated by a team of more than 70 employees from the headquarters. SOLTI is a member of the Spanish Society of Medical Oncology (SEOM) and, in addition to its scientific activity, has a Medical and Patient Education program with multiple annual initiatives. SOLTI’s mission is to utilize disruptive means to develop innovative research that will improve the well-being and future outcomes of cancer patients.
OUR RESEARCH
With a traslational-basis, our trials are grouped under four major research programs:
- Clinical Trial Program: where clinical trials are conducted to evaluate the effectiveness of new strategies for cancer management.
- Window Program: where the biological impact of specific interventions is analyzed before being scaled up to clinical trials with therapeutic intent.
- Biomarker Program: focused on identifying predictive biomarkers of response and mechanisms of resistance.
- Real World Evidence Program: aimed at understanding the real value of different management strategies in clinical practice and predicting potential improvements in them.
BECOME A SOLTI MEMBER
SOLTI members benefit from:
- Development: develop your own ideas, both in clinical trials and in research projects.
- Support: we help you create, finance and execute projects to respond to medical needs.
- Opportunities: Involve your site to participate in a test at different stages of development and access the best therapeutic options for your patients.
- Visibility: establish yourself as a KOL in front of the pharmaceutical industry and get authorship in publications.
- Training: enjoy our activities and training projects for free.
- Networking: we encourage the sharing of molecular data and help young researchers to be principal investigators in different studies.
